[Methodological aspects in bacteriological study of bronchopulmonary diseases in the child. Initial results].
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002512:Cephalothin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002751:Chlortetracycline / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D009355:Neomycin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D000667:Ampicillin; D009355:Neomycin; D002512:Cephalothin; D012293:Rifampin; D002751:Chlortetracycline; D013307:Streptomycin
Su alcuni aspetti metodologici nell'indagine batteriologica delle affezioni broncopolmonari del bambino. Primi risultati.